Altair Nanotechnologies Inc (ALTI) financial statements (2021 and earlier)

Company profile

Business Address 204 EDISON WAY
RENO, NV 89502
State of Incorp.
Fiscal Year End December 31
SIC 289 - Miscellaneous Chemical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13911 
Cash and cash equivalents13911 
Restricted cash and investments0    
Receivables18111 
Inventory, net of allowances, customer advances and progress billings25556
Inventory25556 
Prepaid expense100 
Deferred costs 223 
Prepaid expense and other current assets1 
Other undisclosed current assets1519911 
Total current assets:60312532 
Noncurrent Assets
Property, plant and equipment741266 
Long-term investments and receivables7    
Accounts and financing receivable, after allowance for credit loss7    
Prepaid expense1   
Restricted cash and investments  310 
Other noncurrent assets3 1 
Other undisclosed noncurrent assets18242415 
Total noncurrent assets:103363530 
TOTAL ASSETS:163676062 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:6111 
Accounts payable0    
Accrued liabilities 000 
Employee-related liabilities4111 
Taxes payable0    
Other undisclosed accounts payable and accrued liabilities1    
Debt81267 
Due to related parties82    
Deferred revenue and credits0657 
Other liabilities 000 
Other undisclosed current liabilities17322 
Total current liabilities:114221417 
Noncurrent Liabilities
Long-term debt and lease obligation38 10 
Long-term debt, excluding current maturities29 1  
Capital lease obligations9 00 
Liabilities, other than long-term debt28181412 
Deferred revenue and credits25181412 
Other liabilities3    
Total noncurrent liabilities:66181512 
Total liabilities:179392929 
Stockholders' equity
Stockholders' equity attributable to parent, including:(16)273133 
Common stock00247247 
Additional paid in capital2602591212 
Accumulated other comprehensive income (loss)(0)010 
Accumulated deficit(276)(233)(229)(226) 
Warrants and rights outstanding 000 
Other undisclosed stockholders' equity attributable to parent  (0)(0) 
Other undisclosed stockholders' equity (0)(0)(0) 
Total stockholders' equity:(16)273133 
TOTAL LIABILITIES AND EQUITY:163676062 

Income statement (P&L) ($ in millions)

12/31/2016
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues
(Revenue, Net)
49132 
Cost of revenue(31)(1)(3)(2) 
Cost of goods and services sold4(1)(3)(2) 
Gross profit:18(0)(0)(0) 
Operating expenses(10)(4)(3)(3) 
Operating income (loss):7(4)(3)(4) 
Nonoperating income (expense)(1)000 
Other nonoperating income300  
Net income (loss) available to common stockholders, diluted:7(4)(3)(3) 

Comprehensive Income ($ in millions)

12/31/2016
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net income (loss):7(4)(3)(3) 
Other comprehensive loss (4)(3)(3) 
Other undisclosed comprehensive income10    
Comprehensive income (loss):16(8)(6)(7) 
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)    
Comprehensive income (loss), net of tax, attributable to parent:16(8)(6)(7) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: